Year |
Citation |
Score |
2016 |
Rosero RA, Villares GJ, Bar-Eli M. Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection. Frontiers in Genetics. 7: 112. PMID 27379162 DOI: 10.3389/Fgene.2016.00112 |
0.64 |
|
2016 |
Shoshan E, Braeuer RR, Kamiya T, Mobley AK, Huang L, Vasquez ME, Velazquez-Torres G, Chakravarti N, Ivan C, Prieto VG, Villares GJ, Bar-Eli M. NFAT1 directly regulates IL-8 and MMP-3 to promote melanoma tumor growth and metastasis. Cancer Research. PMID 27013197 DOI: 10.1158/0008-5472.Can-15-2511 |
0.695 |
|
2013 |
Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, et al. Src activation by β-adrenoreceptors is a key switch for tumour metastasis. Nature Communications. 4: 1403. PMID 23360994 DOI: 10.1038/Ncomms2413 |
0.61 |
|
2013 |
Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, et al. Erratum: Corrigendum: Src activation by β-adrenoreceptors is a key switch for tumour metastasis Nature Communications. 4. DOI: 10.1038/Ncomms2903 |
0.555 |
|
2012 |
Villares GJ, Zigler M, Blehm K, Bogdan C, McConkey D, Colin D, Bar-Eli M. Retraction Note: Targeting EGFR in bladder cancer World Journal of Urology. 30: 723-723. PMID 22972001 DOI: 10.1007/S00345-012-0940-Z |
0.553 |
|
2011 |
Zigler M, Kamiya T, Brantley EC, Villares GJ, Bar-Eli M. PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Research. 71: 6561-6. PMID 22009534 DOI: 10.1158/0008-5472.Can-11-1432 |
0.7 |
|
2011 |
Nick AM, Stone RL, Armaiz-Pena G, Ozpolat B, Tekedereli I, Graybill WS, Landen CN, Villares G, Vivas-Mejia P, Bottsford-Miller J, Kim HS, Lee JS, Kim SM, Baggerly KA, Ram PT, et al. Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death. Journal of the National Cancer Institute. 103: 1596-612. PMID 21957230 DOI: 10.1093/Jnci/Djr372 |
0.47 |
|
2011 |
Zigler M, Villares GJ, Dobroff AS, Wang H, Huang L, Braeuer RR, Kamiya T, Melnikova VO, Song R, Friedman R, Alani RM, Bar-Eli M. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Research. 71: 3494-504. PMID 21467165 DOI: 10.1158/0008-5472.Can-10-3555 |
0.681 |
|
2011 |
Villares GJ, Zigler M, Bar-Eli M. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target. Oncotarget. 2: 8-17. PMID 21378407 DOI: 10.18632/Oncotarget.211 |
0.69 |
|
2011 |
Villares GJ, Zigler M, Dobroff AS, Wang H, Song R, Melnikova VO, Huang L, Braeuer RR, Bar-Eli M. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proceedings of the National Academy of Sciences of the United States of America. 108: 626-31. PMID 21187389 DOI: 10.1073/Pnas.1006886108 |
0.705 |
|
2011 |
Braeuer RR, Zigler M, Villares GJ, Dobroff AS, Bar-Eli M. Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment. Seminars in Cancer Biology. 21: 83-8. PMID 21147226 DOI: 10.1016/J.Semcancer.2010.12.007 |
0.699 |
|
2011 |
Pena GNA, Stone RL, Nick AM, Villares GJ, Cruz A, Vivas-Mejias P, Wu Z, English RD, Soman KV, Deavers MT, Zien A, Soldatos T, Jackson DB, Wiktorowicz JE, Torres-Lugo M, et al. Abstract 937: Molecular dynamics of SrcS17 activation in chronic stress-induced tumor growth Cancer Research. 71: 937-937. DOI: 10.1158/1538-7445.Am2011-937 |
0.645 |
|
2010 |
Melnikova VO, Dobroff AS, Zigler M, Villares GJ, Braeuer RR, Wang H, Huang L, Bar-Eli M. CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma. Plos One. 5: e12452. PMID 20805990 DOI: 10.1371/Journal.Pone.0012452 |
0.587 |
|
2010 |
Zigler M, Villares GJ, Dobroff AS, Braeuer RR, Wang H, Huang L, Alani RM, Bar-Eli M. Abstract 2369: The adhesion molecule MCAM/MUC18 regulates the expression of Id-1 and contributes to melanoma invasion and metastasis Cancer Research. 70: 2369-2369. DOI: 10.1158/1538-7445.Am10-2369 |
0.694 |
|
2010 |
Dobroff AS, Melnikova VO, Villares GJ, Zigler M, Braeuer RR, Wang H, Huang L, Bar-Eli M. Abstract 2353: CREB regulates AP-2α transcription to determine the malignant phenotype of melanoma Cancer Research. 70: 2353-2353. DOI: 10.1158/1538-7445.Am10-2353 |
0.657 |
|
2010 |
Nick AM, Stone RL, Spannuth WA, Landen CN, Villares G, Armaiz-Pena G, Carroll AR, Ozpolat B, Tekedereli I, Vivas-Mejia P, Coleman RL, Lopez-Berestein G, Sood AK. Abstract 1044: Silencing p130cas in ovarian carcinoma induces autophagic cell death Cancer Research. 70: 1044-1044. DOI: 10.1158/1538-7445.Am10-1044 |
0.465 |
|
2009 |
Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, Petersson F, Price JE, Schroit A, Prieto VG, Hung MC, Bar-Eli M. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. The Journal of Biological Chemistry. 284: 28845-55. PMID 19703903 DOI: 10.1074/Jbc.M109.042150 |
0.707 |
|
2009 |
Villares GJ, Dobroff AS, Wang H, Zigler M, Melnikova VO, Huang L, Bar-Eli M. Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Research. 69: 6730-7. PMID 19679555 DOI: 10.1158/0008-5472.Can-09-0300 |
0.697 |
|
2009 |
Dobroff AS, Wang H, Melnikova VO, Villares GJ, Zigler M, Huang L, Bar-Eli M. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma. The Journal of Biological Chemistry. 284: 26194-206. PMID 19632997 DOI: 10.1074/Jbc.M109.019836 |
0.71 |
|
2009 |
Armaiz-Pena G, Villares G, Han L, Lin Y, Sanguino A, Deavers M, Gallick G, Bar-Eli M, Lopez-Berestein G, Cole S, Lutgendorf S, Sood A. 5. Molecular mechanisms of Src activation in chronic stress-induced cancer growth Brain, Behavior, and Immunity. 23: S26. DOI: 10.1016/J.Bbi.2009.06.010 |
0.571 |
|
2008 |
Melnikova VO, Villares GJ, Bar-Eli M. Emerging roles of PAR-1 and PAFR in melanoma metastasis. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 1: 103-11. PMID 19308689 DOI: 10.1007/S12307-008-0002-7 |
0.687 |
|
2008 |
Villares GJ, Zigler M, Wang H, Melnikova VO, Wu H, Friedman R, Leslie MC, Vivas-Mejia PE, Lopez-Berestein G, Sood AK, Bar-Eli M. Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. Cancer Research. 68: 9078-86. PMID 18974154 DOI: 10.1158/0008-5472.Can-08-2397 |
0.683 |
|
2008 |
Zigler M, Villares GJ, Lev DC, Melnikova VO, Bar-Eli M. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape. American Journal of Clinical Dermatology. 9: 307-11. PMID 18717605 DOI: 10.2165/00128071-200809050-00004 |
0.625 |
|
2008 |
Kuwai T, Nakamura T, Sasaki T, Kim SJ, Fan D, Villares GJ, Zigler M, Wang H, Bar-Eli M, Kerbel RS, Fidler IJ. Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors. Neoplasia (New York, N.Y.). 10: 489-500. PMID 18472966 DOI: 10.1593/Neo.08200 |
0.669 |
|
2008 |
Merritt WM, Lin YG, Spannuth WA, Fletcher MS, Kamat AA, Han LY, Landen CN, Jennings N, De Geest K, Langley RR, Villares G, Sanguino A, Lutgendorf SK, Lopez-Berestein G, Bar-Eli MM, et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. Journal of the National Cancer Institute. 100: 359-72. PMID 18314475 DOI: 10.1093/Jnci/Djn024 |
0.576 |
|
2007 |
Villares GJ, Zigler M, Blehm K, Bogdan C, McConkey D, Colin D, Bar-Eli M. Targeting EGFR in bladder cancer. World Journal of Urology. 25: 573-9. PMID 17690890 DOI: 10.1007/S00345-007-0202-7 |
0.633 |
|
2006 |
Blehm KN, Spiess PE, Bondaruk JE, Dujka ME, Villares GJ, Zhao YJ, Bogler O, Aldape KD, Grossman HB, Adam L, McConkey DJ, Czerniak BA, Dinney CP, Bar-Eli M. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4671-7. PMID 16899617 DOI: 10.1158/1078-0432.Ccr-06-0407 |
0.599 |
|
Show low-probability matches. |